Home | All results_reference

[RDF data]
Results Reference #1208

Resource URI: http://static.linkedct.org/resource/results_reference/1208
linkedct:citation Miller TP, Unger JM, Spier C, et al.: Effect of adding ibritumomab tiuxetan (Zevalin) radioimmunotherapy consolidation to three cycles of CHOP plus involved-field radiotherapy for limited-stage aggressive diffuse B-cell lymphoma (SWOG 0313). [Abstract] Blood 112 (11): A-3598, 2008.
rdfs:label Results Reference #1208
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00070018>
linkedct:results_reference_id 1208 (xsd:int)
rdf:type linkedct:results_reference